OncLive® Scientific Interchange and Workshop Podcast Series: Management of HER2+ Breast Cancer - Episode 3

Advances in Metastatic HER2-Positive Breast Cancer

OncLive Staff

Dr Gradishar and colleagues highlight key clinical trials such as DESTINY-Breast01, HER2CLIMB, NALA, and SOPHIA in the setting of advanced HER2-positive breast cancer and discuss the practical considerations of these data.